Drug Profile
DEGR-VIIa
Alternative Names: Active-site inactivated factor VIIa; DEG-Factor VIIaLatest Information Update: 21 Sep 2000
Price :
$50
*
At a glance
- Originator Unknown
- Developer Novo Nordisk; ZymoGenetics
- Class Thrombolytics
- Mechanism of Action Factor VIIa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Coronary artery restenosis; Thrombosis; Vascular restenosis
Most Recent Events
- 21 Sep 2000 Discontinued-Preclinical for Coronary artery restenosis in Europe (IV)
- 21 Sep 2000 Discontinued-Preclinical for Coronary artery restenosis in USA (IV)
- 21 Sep 2000 Discontinued-Preclinical for Thrombosis in Europe (IV)